Glyoxalase I (GLO1) is the first of the two glyoxalase-pathway enzymes. It catalyzes the formation of S-d-lactoyltrypanothione from the non-enzymatically formed hemithioacetal of methylglyoxal and reduced trypanothione. In order to understand its substrate binding and catalytic mechanism, GLO1 from Leishmania infantum was cloned, overexpressed in Escherichia coli, purified and crystallized. Two crystal forms were obtained: a cube-shaped form and a rodshaped form. While the cube-shaped form did not diffract X-rays at all, the rod-shaped form exhibited diffraction to about 2.0 Å resolution. The crystals belonged to space group P2 1 2 1 2, with unit-cell parameters a = 130.03, b = 148.51, c = 50.63 Å and three dimers of the enzyme per asymmetric unit.
Introduction
Trypanosomatids are the causative agents of leishmaniasis, a group of diseases that are widespread in the Third World and the Mediterranean Basin and that affect nearly 12 million people according to the World Health Organization. Effective therapeutic approaches for leishmaniasis may rely on unique biochemical characteristics that set trypanosomatids apart from other eukaryotic cells. Two of these features are the compartmentalization of glycolysis into a specific organelle, the glycosome (Michels et al., 2000; Hannaert et al., 2003) , and the functional replacement of glutathione by trypanothione [N 1 ,N 8 -bis(glutathionyl)spermidine], a spermidine-glutathione conjugate (Mü ller et al., 2003; Flohé et al., 1999) . By synergistically exploiting the disruption of trypanothione-dependent biochemical processes and the inhibition of the glycolytic pathway (Bakker et al., 1999) , both of which are essential for parasite survival, new therapeutic targets may be identified. One of these trypanothionedependent systems is the glyoxalase pathway, which is responsible for the elimination of methylglyoxal, a toxic and mutagenic compound (Thornalley, 1998) that originates from either spontaneous degradation of triose phosphates or a side reaction of triphosphate isomerase.
In trypanosomatids, the methylglyoxal elimination system is composed of two enzymes ( Fig. 1 ): glyoxalase I (lactoylglutathione lyase; EC 4.4.1.5; GLO1) and glyoxalase II (hydroxyacylglutathione hydrolase; EC 3.1.2.6; GLO2). These enzymes are specific for trypanothione and lactoyltrypanothione, respectively (Sousa Silva et al., 2005; Irsch & Krauth-Siegel, 2004) , although GLO1 also catalyses the reaction of the glutathione-methylglyoxal hemithioacetal (Sousa Silva et al., 2005) .
In eukaryotes, GLO1 is a homodimeric protein consisting of two subunits of 141 residues each (molecular weight 18.2 kDa). In prokaryotes the enzyme is also dimeric (Sukdeo et al., 2004) , while in yeast (Thornalley, 2003) and plasmodia (Iozef et al., 2003) the enzyme is monomeric, although two genes for the enzyme exist owing to a gene-duplication event. The relative size and structure of the enzyme is conserved across all of the above organisms. X-ray structures of GLO1 from various organisms are known, including the enzymes from Escherichia coli (EcGLO1; PDB entries 1f9z, 1fa5, 1fa6, 1fa7 and 1fa8; He et al., 2000) , Homo sapiens (HsGLO1; PDB entries 1fro, 1qin, 1qip and 1bh5; Cameron et al., 1997 Cameron et al., , 1999 Ridderstrom et al., 1998) and Leishmania major (LmGLO1; PDB entry 2c21; Ariza et al., 2006) . All of these structures display a homodimeric arrangement of the molecules.
Although LmGLO1 shows 97% sequence identity to the enzyme from L. infantum (LiGLO1), the forms of leishmaniasis caused by the two organisms are very different. This may be attributed to differences in stage-regulated gene-expression patterns between L. infantum and L. major (Rochette et al., 2008) , but may also arise from amino-acid differences in the respective enzymes.
Here, we report the cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of LiGLO1. In addition, the structure of LiGLO1 was solved by molecular replacement. Together with the previously solved structure of L. infantum GLO2 (Silva et al., 2008) , the refined structure of LiGLO1 will lead to a better understanding of the glyoxalase pathway in trypanosomatids as well as providing novel insights into the evolutionary pressure towards trypanothione specificity.
Materials and methods

Cloning and expression
The LiGLO1 gene (GenBank accession No. DQ294973) was amplified from L. infantum genomic DNA. The PCR product was cloned [forward primer 5 0 -CCGCGCACATATGCCGTCTCGTCG-TAT-3 0 , containing an NdeI restriction site (bold); reverse primer 5 0 -CACCGCTCGAGTTACGCAGTGCCCTGCTC-3 0 , containing an XhoI restriction site (bold) immediately after the stop codon] into the NdeI/XhoI-digested expression vector pET28a (Novagen, Gibbstown, USA), which was then transformed into E. coli BL21-Codon-Plus (Stratagene, La Jolla, California, USA). The correct cloning of the open reading frame was confirmed by sequencing. The final protein sequence was preceded by MGSSHHHHHHSSGLVPRGSH, containing a His 6 tag (bold) and a thrombin cleavage site (italics). For overexpression of N-terminally His 6 -tagged LiGLO1, E. coli BL21-CodonPlus transformants were grown in LB medium containing 50 mg ml À1 kanamycin and 34 mg ml À1 chloramphenicol at 310 K. Expression of His 6 -tagged LiGLO1 was induced at a culture OD 600 of 0.6 with 0.1 mM isopropyl -d-1-thiogalactopyranoside (IPTG) for 3 h at 310 K. Cells were harvested by centrifugation at 7800g for 30 min at 277 K and the cell pellets were frozen at 253 K.
Purification
The cell pellet was suspended in 10 ml buffer A (50 mM bis-tris pH 6.3, 200 mM NaCl; all chemicals were obtained from Carl Roth, Karlsruhe, Germany) per gram of cells and lysed by sonication for 10 min at 35% power using 0.4 s pulses with 0.9 s breaks between the pulses at 277 K. The soluble fraction obtained by centrifugation at 38 000g for 40 min at 277 K was filtered through a 0.22 mm membrane before being applied onto an affinity-chromatography column charged with Co 2+ for purification at room temperature. The fusion protein, which contained an N-terminal tail consisting of six histidine residues and a thrombin cleavage site, was eluted in buffer A supplemented with 500 mM imidazole. The N-terminal His 6 tag was cleaved using a Thrombin Cleavage Kit (Novagen) with optimized cleavage conditions (1:200 thrombin dilution overnight at 293 K). The cleaved protein was directly applied onto a gel-filtration column (Superdex S75 16/60, GE Healthcare) equilibrated with buffer A for further purification. The purity of the recombinant enzyme was estimated by SDS-PAGE. Peptide mass fingerprinting by MALDI-FTICR MS was used to confirm the identity of the expressed protein (Shevchenko et al., 2006) . LiGLO1 was concentrated to 15 mg ml À1 in buffer A using a Vivaspin 15 (molecular-weight cutoff 10 000) concentrator (Sartorius Stedim Biotech, Gö ttingen, Germany). The protein concentration was determined using a Peqlab Biotechnologie GmbH NanoDrop ND-1000 spectrometer at 280 nm, assuming an estimated LiGLO1 extinction coefficient of 20 400 M À1 cm À1 as calculated using the ProtParam tool (Gasteiger et al., 2005) for a protein of molecular weight 18.2 kDa. Buffer A was optimized by ligand-assisted monitoring of thermal protein unfolding in a ThermoFluor (Bio-Rad, California, USA) experiment (data not shown).
Crystallization
Initial crystallization screening was performed at the High Throughput Crystallization facility at the EMBL Hamburg Outstation (Mueller-Dieckmann, 2006) using commercially available crystal screens and the sitting-drop vapour-diffusion method. The drops consisted of 0.5 ml protein solution at a concentration of 15 mg ml À1 and 0.5 ml reservoir solution and were equilibrated over 80 ml reservoir solution using 96-well format Greiner plates. Two crystal forms (Fig. 2) Metabolism of methylglyoxal in Leishmania spp. Methylglyoxal originates nonenzymatically (n.e.) from glyceraldehyde phosphate or dihydroxyacetone phosphate and is further catabolized in the glyoxalase pathway. Here, methylglyoxal reacts non-enzymatically with reduced trypanothione [T(SH) 2 ], forming a hemithioacetal. This hemithioacetal is then isomerized by GLO1, forming the thiol ester S-d-lactoyltrypanothione, which is subsequently hydrolysed to d-lactate by GLO2, regenerating T(SH) 2 . pH 8.5] of JBScreen Classic 8 from Jena Bioscience (Jena, Germany). Crystals of form 2 were then further improved by applying the hanging-drop vapour-diffusion method using the tools from Nextal Biotechnology (Montreal, Canada). Drops were prepared by mixing 2 ml protein solution with 2 ml reservoir solution consisting of 62%(v/v) MPD and 100 mM Tris-HCl pH 8.5 and were equilibrated over 1 ml reservoir solution. This resulted in rod-shaped crystals (Fig. 2c ), which grew within 3 d at 293 K to maximum dimensions of 0.50 Â 0.15 Â 0.15 mm.
Diffraction data collection and processing
For diffraction experiments, the crystals were directly flash-cooled in the cryostream without any additional cryoprotectant. The cubeshaped crystals (Fig. 2a ) did not show any X-ray diffraction on beamline ID23-2 at the European Synchrotron Research Facility (ESRF, Grenoble, France). However, the initial rod-shaped crystals from the second condition (Fig. 2b) diffracted to 3.0 Å resolution on the same beamline (Table 1 ) and a complete diffraction data set was collected. The optimized form 2 crystals diffracted to about 2.0 Å on EMBL beamline X12 [Deutsches Elektronen-Synchrotron (DESY), Hamburg, Germany]. Again, a complete diffraction data set was collected to 2.1 Å resolution (Table 1) . All data were processed and scaled using XDS (Kabsch, 1993 (Kabsch, , 2010 . The R factors R r.i.m. (redundancy-independent merging R factor) and R p.i.m. (precisionindicating merging R factor) (Weiss, 2001) were obtained using the program RMERGE (available from http://www.embl-hamburg.de/ msweiss/projects/msw_qual.html or from MSW upon request). The optical resolution was calculated using the program SFCHECK (Vaguine et al., 1999) and the self-rotation function was calculated using the program MOLREP (Vagin & Teplyakov, 1997) for data between 99 and 4.0 Å resolution.
Results and discussion
After purification of LiGLO1 using cobalt affinity chromatography and a gel-filtration step, the protein was about 95% pure as estimated by SDS-PAGE. The total yield of the purification process was 20 mg of protein per litre of culture. The crystallization behaviour was observed to be similar to that of the enzyme from L. major (Ariza et al., 2005) . The initial rod-shaped form 2 crystals (Fig. 2b) diffracted to about 3.0 Å resolution, while the optimized crystals (Fig. 2c ) diffracted X-rays to beyond 2.1 Å resolution using synchrotron radiation. Two complete diffraction data sets were collected (Table 1) . The crystals belonged to space group P2 1 2 1 2, with unit-cell para- (Matthews, 1968) and solvent content calculated based on a subunit molecular weight of 18.2 kDa (predicted from the sequence) estimated the most likely asymmetric unit content to be either four or six molecules. Assuming the presence of three dimers per asymmetric unit, the Matthews coefficient was 2.2 Å 3 Da À1 and the solvent content was 45.3% (Kantardjieff & Rupp, 2003; Matthews, 1968) . For two dimers the respective values would be 3.4 Å 3 Da À1 and 63.6%. A detailed examination of the self-rotation function revealed noncrystallographic peaks on the = 180 section (Fig. 3 ). It appears to be the case that at least two additional twofold axes are present on this section and that all of them lie in the xy plane. However, without knowledge of the structure the self-rotation function does not allow determination of the number of dimers per asymmetric unit with certainty.
The structure of LiGLO1 was solved by molecular replacement using the related structure of glyoxalase I from L. major (PDB entry 2c21; Ariza et al., 2006) and the lower resolution data set collected from the initial form 2 crystals. After placing three dimers in the asymmetric unit, the correlation coefficient was 64.2% and the R factor to 3.5 Å resolution was 39.6%. This essentially confirmed the correctness of the structure solution. Refinement of the structure against the high-resolution data set collected from the optimized form 2 crystals is currently under way. In retrospect, the self-rotation function (Fig. 3) can be examined and interpreted using the known structure as a guide. The three dimers of LiGLO1 arrange themselves in a pseudo-D3 symmetric arrangement, with the threefold axis only about 14 away from the crystallographic z axis and all twofold axes close to the xy plane. A very similar arrangement was also observed in the structure of LmGLO1 (Ariza et al., 2005) .
Together with the previously determined structure of L. infantum GLO2 (Silva et al., 2008) , the LiGLO1 structure will not only allow a comprehensive study of the glyoxalase pathway in trypanosomatids but will also provide insight into the reasons for trypanothione selection during evolution.
